PL400715A1 - Method for synthesizing compounds of K₂LnF₅ fluoride anhydrous - Google Patents

Method for synthesizing compounds of K₂LnF₅ fluoride anhydrous

Info

Publication number
PL400715A1
PL400715A1 PL400715A PL40071512A PL400715A1 PL 400715 A1 PL400715 A1 PL 400715A1 PL 400715 A PL400715 A PL 400715A PL 40071512 A PL40071512 A PL 40071512A PL 400715 A1 PL400715 A1 PL 400715A1
Authority
PL
Poland
Prior art keywords
k2lnf5
synthesizing compounds
anhydrous
fluoride anhydrous
fluoride
Prior art date
Application number
PL400715A
Other languages
Polish (pl)
Inventor
Radoslaw Pawel Lisiecki
Piotr Paweł Solarz
Witold Ryba-Romanowski
Grażyna Zofia Dominiak-Dzik
Bogusław Janusz Macalik
Przemysław Jacek Dereń
Original Assignee
Instytut Niskich Temperatur I Badan Strukturalnych Pan Im. Wlodzimierza Trzebiatowskiego
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Niskich Temperatur I Badan Strukturalnych Pan Im. Wlodzimierza Trzebiatowskiego filed Critical Instytut Niskich Temperatur I Badan Strukturalnych Pan Im. Wlodzimierza Trzebiatowskiego
Priority to PL400715A priority Critical patent/PL400715A1/en
Publication of PL400715A1 publication Critical patent/PL400715A1/en

Links

Landscapes

  • Crystals, And After-Treatments Of Crystals (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)

Abstract

Opisano sposób syntezy bezwodnych zwiazków fluorków K2LnF5, gdzie Ln oznacza wszystkie trójwartosciowe jony lantanowców Ln = La - Lu, przy wykorzystaniu znanego tygla grafitowego oraz atmosfery inertnej. Sposób charakteryzuje sie tym, ze mieszanine stechiometryczna zlozona z 2KF oraz LnF3 homogenizujemy, a nastepnie umieszczamy na czas od 2 do 6 dni, w tyglu grafitowym ulokowanym w piecu rozgrzanym do temperatury od 600-650°C.The method of synthesis of anhydrous K2LnF5 fluoride compounds was described, where Ln stands for all trivalent lanthanide ions Ln = La - Lu, using a known graphite crucible and inert atmosphere. The method is characterized by the fact that the stoichiometric mixture consisting of 2KF and LnF3 is homogenized and then placed for 2 to 6 days in a graphite crucible located in a preheated oven to a temperature of 600-650 ° C.

PL400715A 2012-09-10 2012-09-10 Method for synthesizing compounds of K₂LnF₅ fluoride anhydrous PL400715A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL400715A PL400715A1 (en) 2012-09-10 2012-09-10 Method for synthesizing compounds of K₂LnF₅ fluoride anhydrous

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL400715A PL400715A1 (en) 2012-09-10 2012-09-10 Method for synthesizing compounds of K₂LnF₅ fluoride anhydrous

Publications (1)

Publication Number Publication Date
PL400715A1 true PL400715A1 (en) 2013-07-08

Family

ID=48748842

Family Applications (1)

Application Number Title Priority Date Filing Date
PL400715A PL400715A1 (en) 2012-09-10 2012-09-10 Method for synthesizing compounds of K₂LnF₅ fluoride anhydrous

Country Status (1)

Country Link
PL (1) PL400715A1 (en)

Similar Documents

Publication Publication Date Title
MX2010006421A (en) Organic compounds.
PH12015502615A1 (en) Chemical compounds
PE20200387A1 (en) NOVEL PROCESS FOR THE ELABORATION OF COMPOUNDS FOR USE IN THE TREATMENT OF CANCER
ZA201000079B (en) Organic compounds
MX367618B (en) Substituted benzofuranyl and benzoxazolyl compounds and uses thereof.
PH12017501690A1 (en) Crystal of 3,5-disubstituted benzene alkynyl compound
FR2918050B1 (en) IZM-2 CRYSTALLIZED SOLID AND PROCESS FOR PREPARING THE SAME
MY192641A (en) Novel pyrimidine and pyridine compounds and their usage
TN2010000167A1 (en) Organic compounds
TW200637863A (en) Organic compounds
MY164776A (en) Heterocyclic compound
MX360706B (en) 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases.
TW200630366A (en) Organic compounds
MX2015011566A (en) Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same.
MY166449A (en) Pharmaceutical composition of rosuvastatin calcium
PT2393363E (en) Use of a sulfurous, heteroaromatic acid analogue as a bactericide
TN2015000372A1 (en) A method for concentrating rare-earth metals in phosphogypsum
PH12015500794A1 (en) Monohydrate crystal of fimasartan potassium salt, method for preparing same, and pharmacological composition comprising same
PH12014501712B1 (en) Novel morpholinyl derivatives useful as mogat-2-inhibitors
MX2015015524A (en) Batch composition for producing an unshaped refractory ceramic product, method for producing a fired refractory ceramic product, fired refractory ceramic product, and use of an unshaped refractory ceramic product.
IN2014MN01671A (en)
BR112014014762A8 (en) method for preparing cysteine or a derivative thereof using a novel o-phosphferin sulfhydrylase
MX2013005410A (en) 5-halogenopyrazole(thio)carboxamides.
PL400715A1 (en) Method for synthesizing compounds of K₂LnF₅ fluoride anhydrous
MX363334B (en) A crystalline anhydrous form of cabazitaxel, process for the preparation and pharmaceutical compositions thereof.